Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
Isoform
100%
Colon
100%
Tropomyosin
100%
RNAI
75%
Cancer Cell
50%
Rosiglitazone
50%
Sulfasalazine
50%
Molecular Mechanism
50%
C-Terminus
25%
Amino Acids
25%
Protein Expression
25%
Angiogenesis
25%
Peroxisome Proliferator-Activated Receptor
25%
PPAR Agonist
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Tumor-Related Gene
25%
Sulfapyridine
25%
Flow Cytometry
25%
Polymerase Chain Reaction
25%
Programmed Cell Death
25%
Medicine and Dentistry
Neoplasm
100%
Tropomyosin
100%
Mesalazine
100%
Colon Carcinoma
50%
RNAI
50%
Cancer Cell
33%
Rosiglitazone
33%
Salazosulfapyridine
33%
Chemoprophylaxis
16%
Epithelial Cell
16%
Protein Expression
16%
Angiogenesis
16%
Carboxy Terminal Sequence
16%
Programmed Cell Death
16%
Ulcerative Colitis
16%
Fluorescence Activated Cell Sorting
16%
Colon
16%
Amino Acid
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Peroxisome Proliferator Activated Receptor
16%
Colorectal Carcinoma
16%
Tumor-Related Gene
16%
Anticarcinogen
16%
Sulfapyridine
16%
Peroxisome Proliferator Activated Receptor Agonist
16%
Polymerase Chain Reaction
16%
Keyphrases
Tropomyosin
100%
Mesalamine
100%
Colonic Neoplasia
100%
Tc22
100%
Small Interfering RNA (siRNA)
25%
Molecular Mechanism
16%
Protein Level
16%
Colon Cancer Cells
16%
Rosiglitazone
16%
Gene Level
16%
Sulfasalazine
16%
LS180
16%
Transcript Level
8%
Cancer Genes
8%
Apoptosis
8%
Adhesion
8%
Protein Expression
8%
Quantitative PCR
8%
Tissue Remodeling
8%
Angiogenesis
8%
Ulcerative Colitis
8%
Colon Cancer
8%
Protective Behavior
8%
Fluorescence-activated Cell Sorting
8%
Peroxisome Proliferator-activated Receptor
8%
Transfected Cells
8%
Chemoprevention
8%
Peroxisome Proliferator-activated Receptor Agonists
8%
Colorectal Carcinoma
8%
Polymerase Chain Reaction Array
8%
Time Change
8%
Sulfapyridine
8%
C-terminal Amino Acids
8%
Carcinogenic Mechanism
8%
Level Changes
8%
Cellular Expression
8%
Dose-dependent
8%
Antineoplastic
8%
Molecular Effects
8%
Alternatively Spliced Variants
8%
Normal Colon Epithelial Cells
8%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Aminosalicylic Acid
100%
Tropomyosin
100%
Colon Carcinoma
50%
Rosiglitazone
33%
Sulfasalazine
33%
Malignant Neoplasm
16%
Peroxisome Proliferator Activated Receptor
16%
Amino Acid
16%
PPAR Agonist
16%
Ulcerative Colitis
16%
Fluorescence Activated Cell Sorting
16%
Colorectal Carcinoma
16%
Anticarcinogen
16%
Sulfapyridine
16%